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Ronglai Shen, Sijian Wang, and Qianxing Mo

Abstract

High resolution microarrays and second-generation sequencing platforms are powerful tools to investigate genome-wide alterations in DNA copy number, methylation, and gene expression associated with a disease. An integrated genomic profiling approach measuring multiple omics data types simultaneously in the same set
of biological samples would render an integrated data resolution that would not be
available with any single data type. In a previous publication (Shen et al., 2009),
we proposed a latent variable regression with a lasso constraint (Tibshirani, 1996)
for joint modeling of multiple omics data types to identify common latent variables that can be used to cluster patient samples into biologically and clinically
relevant disease subtypes. The resulting sparse coefficient vectors (with many
zero elements) can be used to reveal important genomic features that have significant contributions to the latent variables. In this study, we consider a combination
of lasso, fused lasso (Tibshirani et al., 2005) and elastic net (Zou & Hastie, 2005)
penalties and use an iterative ridge regression to compute the sparse coefficient
vectors. In model selection, a uniform design (Fang & Wang, 1994) is used to
seek “experimental” points that scattered uniformly across the search domain for
efficient sampling of tuning parameter combinations. We compared our method
to sparse singular value decomposition (SVD) and penalized Gaussian mixture
model (GMM) using both real and simulated data sets. The proposed method
is applied to integrate genomic, epigenomic, and transcriptomic data for subtype
analysis in breast and lung cancer data sets.
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Abstract
High resolution microarrays and second-generation sequencing platforms are powerful tools to investigate genome-wide alterations in DNA copy number, methylation, and
gene expression associated with a disease. An integrated genomic proﬁling approach
measuring multiple omics data types simultaneously in the same set of biological samples would render an integrated data resolution that would not be available with any
single data type. In a previous publication (Shen et al., 2009), we proposed a latent
variable regression with a lasso constraint (Tibshirani, 1996) for joint modeling of multiple omics data types to identify common latent variables that can be used to cluster
patient samples into biologically and clinically relevant disease subtypes. The resulting
sparse coeﬃcient vectors (with many zero elements) can be used to reveal important genomic features that have signiﬁcant contributions to the latent variables. In this study,
we consider a combination of lasso, fused lasso (Tibshirani et al., 2005) and elastic net
(Zou & Hastie, 2005) penalties and use an iterative ridge regression to compute the
sparse coeﬃcient vectors. In model selection, a uniform design (Fang & Wang, 1994) is
used to seek “experimental” points that scattered uniformly across the search domain
for eﬃcient sampling of tuning parameter combinations. We compared our method
to sparse singular value decomposition (SVD) and penalized Gaussian mixture model
(GMM) using both real and simulated data sets. The proposed method is applied to
integrate genomic, epigenomic, and transcriptomic data for subtype analysis in breast
and lung cancer data sets.
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1

Introduction

Clustering analysis is an unsupervised learning method that aims to group data into distinct
clusters based on a certain measure of similarity among the data points. Clustering analysis has many applications in a wide variety of ﬁelds including pattern recognition, image
processing and bioinformatics. In gene expression microarray studies, clustering cancer samples based on their gene expression proﬁle has revealed molecular subgroups associated with
histopathological categories, drug response, and patient survival diﬀerences (Perou et al.,
1999; Alizadeh et al., 2000; Sorlie et al., 2001; Lapointe et al., 2003; Hoshida et al., 2003).
In the past few years, integrative genomic studies are emerging at a fast pace where in addition to gene expression data, genome-wide data sets capturing somatic mutation patterns,
DNA copy number alterations, DNA methylation changes are simultaneously obtained in
the same biological samples. A fundamental challenge in translating cancer genomic ﬁndings
into clinical application lies in the ability to ﬁnd “driver” genetic and genomic alterations
that contribute to tumor initiation, progression, and metastasis (Chin & Gray, 2008; Simon, 2010). As integrated genomic studies have emerged, it has become increasingly clear
that true oncogenic mechanisms are more visible when combining evidence across patterns
of alterations in DNA copy number, methylation, gene expression and mutational proﬁles
(TCGA Network, 2008, 2011). Integrative analysis of multiple “omic” data types can help
the search for “drivers” by uncovering genomic features that tend to be dysregulated by multiple mechanisms (Chin & Gray, 2008). A classic example is the tumor-suppressor protein
INK4A (encoded by CDKN2A), which can be inactivated through homozygous loss (copy
number), epigenetic silencing (by promoter methylation), or loss-of-function mutations in
the protein (Sharpless, 2005). Analogously, the HER2 oncogene can be activated through
DNA ampliﬁcation and mRNA overexpression which we will discuss further in our motivating example.
In this paper, we focus on class discovery problem given multiple omics data sets (multidimensional data) for tumor subtype discovery. A major challenge in subtype discovery
based on gene expression microarray data is that the clinical and therapeutic implications
for most existing molecular subtypes of cancer are largely unknown. A confounding factor is
that expression changes may be related to cellular activities independent of tumorigenesis,
and therefore leading to subtypes that may not be directly relevant for diagnostic and prognostic purposes. By contrast, as we have shown in our previous work (Shen et al., 2009), a
joint analysis of multiple omics data types oﬀer a new paradigm to gain additional insights.
Individually, none of the genomic-wide data type alone can completely capture the complexity of the cancer genome or fully explain the underlying disease mechanism. Collectively,
however, true oncogenic mechanisms may emerge as a result of joint analysis of multiple
genomic data types.
Somatic DNA copy number alterations are key characteristics of cancer (Beroukhim et al.,
2
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2010). Copy number gain or ampliﬁcation may lead to activation of oncogenes (e.g., HER2 in
Figure 1). Tumor suppressor genes can be inactivated by copy number loss. High-resolution
array-based comparative genomic hybridization (aCGH) and SNP arrays have become dominant platforms for generating genome-wide copy number proﬁles. The measurement typical
of aCGH platforms is a log-ratio of normalized intensities of genomic DNA in experimental
versus control samples. For SNP arrays, copy number measures are represented by log of
total copy number (logR) or parent-speciﬁc copy number as captured by a B-allele frequency
(BAF) (Chen et al., 2011; Olshen et al., 2011). Both platforms generate contiguous copy
number measures along ordered chromosomal locations (an example is given in Figure 6).
Spatial smoothing methods are desirable for modeling copy number data.
In addition to copy number aberrations, there is a widespread DNA methylation changes
(at CpG dinucleotide sites) in the cancer genome. DNA methylation is the most studied
epigenetic event in cancer (Holliday, 1979; Feinberg & Vogelstein, 1983; Laird, 2003, 2010).
Tumor suppressor genes are frequently inactivated by hypermethylation (increased methylation of CpG sites in the promoter region of the gene), and oncogenes can be activated
through promoter hypomethylation. DNA methylation arrays measure the intensities of
methylated probes relative to unmethylated probes for tens of thousands of CpG sites located at promoter regions of protein coding genes. M-values are calculated by taking log
ratios of methylated and unmethylated probe intensities (Irizarry et al., 2008), similar to the
M-values used for gene expression microarrays which quantify the relative expression level
(abundance of a gene’s mRNA transcript) in cancer samples compared to a normal control.
In this paper, we focus on class discovery problem given multiple omics data sets for tumor subtype discovery. Suppose t = 1, · · · , T diﬀerent genome-scale data types (DNA copy
number, methylation, mRNA expression, etc.) are obtained in j = 1, · · · , n tumor samples.
Let X t be the pt × n data matrix where xi denote the ith row and xj the jth column of
X t . Rows are genomic features and columns are samples. For ease of presentation, we omit
the data type index t for vector and scalar quantities when in clear context. Here we use
the term genomic feature and the corresponding feature index i in the equations throughout
the paper to refer to either a protein-coding gene (typically for expression and methylation
data) or ordered genomic elements that does not necessarily have a one-to-one mapping to
a speciﬁc gene (copy number measure along chromosomal positions) depending on the data
type.
Let Z be a g × n matrix where rows are samples and columns are latent variables. Latent
variables can be interpreted as “fundamental” variables that determine the values of the
original p variables (Jolliﬀe, 2002). In our context, we use latent variables to represent disease
driving factors (underlying the wide spectrum of genomic alterations of various types)∑that
determine biologically and clinically relevant subtypes of the disease. Typically, g ≪ t pt ,
providing a low-dimension latent subspace to the original genomic feature space. Following
a similar argument for reduced-rank linear discriminant analysis in (Hastie et al., 2009), a
3
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rank-g approximation where g ≤ K − 1 is suﬃcient for separating K clusters among the n
data points. For the rest of the paper, we assume the dimension of Z is (K − 1) × n with
mean zero and identity covariance matrix. A joint latent variable model expressed in matrix
form is:
X t = W t Z + E t , t = 1, · · · , T.
(1)
In the above, W t is a pt × (K − 1) coeﬃcient (or loading) matrix relating X t and Z with
wj being the jth row and wk the kth column of W t , and E is a pt × n matrix where the
column vectors ej , j = 1, · · · , n represent uncorrelated error terms that follow a multivariate
distribution with mean zero and a diagonal covariance matrix Ψt = (σ12 , · · · , σp2t ). Each data
matrix is row-centered and the intercept term is omitted.
Equation (1) provides an eﬀective integration framework in which the latent variables
Z = (z 1 , · · · , z K−1 ) are common for all data types, representing a probabilistic low-rank
approximation simultaneously to the T original data matrices. In Section 3.2, we point out
its connection and diﬀerences from singular value decomposition (SVD). In Sections 6 and 7,
we illustrate that applying SVD to combined data matrix broadly fails to achieve an eﬀective
integration of various data types.
Equation (1) is the basis of our initial work (Shen et al., 2009) in which we introduced
an integrative model called iCluster. We considered a soft-thresholding estimate of W t that
continuously shrink the coeﬃcients for noninformative features toward zero. In this paper,
we present a sparse iCluster framework that formally incorporate various sparsity constraints
for the estimation of W t . In particular, sparse iCluster is a penalized latent variable regression that requires columns of W t in equation (1) to be sparse (many zero entries) in order
to identify genomic features that have important contributions to the latent variables. The
motivation for sparse coeﬃcient vectors is clearly indicated by Figure 1 panels C and D. A
basic sparsity-inducing approach is to use a lasso constraint (Tibshirani, 1996).
A limitation of the lasso approach, however, is that it ignores any ordering or grouping
of the elements in W t . Figure 6 gives an example of aCGH data from Chitale et al. (2009)
where copy number measurements show gains or losses in contiguous segments along chromosomal positions. We consider the fused lasso penalty (Tibshirani et al., 2005) to account
for the spatial dependencies among neighboring features in copy number data such that the
eﬀects associated with regions of chromosomal aberration can be estimated in a consistent
way. In gene expression data, such strong positional dependency is not expected. However,
sets of genes involved in the same biological pathway are often highly correlated in their
expression proﬁles. The elastic net penalty proposed by Zou & Hastie (2005) is useful to
encourage a grouping eﬀect by selecting strongly correlated features together. We use an
iterative ridge regression for computing sparse coeﬃcient vectors. Details of the algorithm
will be discussed in Section 4.

4
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In Section 3, we present the methodological details of the latent variable regression combined with lasso, elastic net and fused lasso penalty terms. To determine the optimal combination of the penalty parameter values, a very large search space needs to be covered
which presents a computational challenge. An exhaustive grid search is ineﬀective. We use
a uniform design by Fang and Wang (1994) that seeks “experimental” points that scattered uniformly across the search domain which has superior convergence rates than the
conventional grid search (Section 3.3). Section 4 presents an EM algorithm for maximizing
the penalized data log-likelihood. The number of clusters K is unknown and must be estimated. Section 5 discuss the estimation of K based on a cross-validation approach. Section
6 presents results from real data applications. In particular, Section 6.1 presents an integrative analysis of epigenomic and transcriptomic proﬁling data using a breast cancer data
set (Holm et al., 2010). In Section 6.2, we illustrate our proposed method to construct a
genome-wide portrait of copy number induced gene expression changes using a lung cancer data set (Chitale et al., 2009). Section 7 presents results from simulation studies. We
conclude the paper with a brief summary in Section 8.

2

Motivating examples

Pollack et al. (2002) used customized microarrays to generate measurements of DNA copy
number and mRNA expression in parallel for 37 primary breast cancer and 4 breast cancer
cell line samples. Here the number of data type T = 2. In the mRNA expression data matrix
X 1 , the individual element xij refers to the observed expression of the ith gene in the jth
tumor. In the DNA copy number data matrix X 2 , the individual element xij refers to the
observed log-ratio of tumor versus normal copy number of the ith gene in the jth tumor. In
this example, both data types have gene-centric measurement by design.
A heatmap of the genomic features on chromosome 17 is plotted in Figure 1. In the
heatmap, rows are genes ordered by their genomic position and columns are samples ordered
by hierarchical clustering (panels A) or by lasso iCluster (panels B). There are two main
subclasses in the 41 samples: the cell line subclass (samples labeled in red) and the HER2
tumor subclass (samples labeled in green). It is clear in Figure 1A that these subclasses
cannot be distinguished well from separate hierarchical clustering analyses.
Separate clustering followed by manual integration as depicted in Figure 1A remains the
most frequently applied approach to analyze multiple omics data sets in the current literature
for its simplicity and the lack of a truly integrative approach. However, Figure 1A clearly
shows its lack of consistency in cluster assignment and poor correlation of the outcome with
biological and clinical annotation. As we will illustrate in the simulation study in Section 7,
separate clustering can fail drastically in estimating the true number of clusters, classifying
samples to the correct clusters, and selecting cluster-associated features. Several limitations
of this common approach are responsible for its poor performance:
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Figure 1: A motivating example using the Pollack data set to demonstrate that a joint
analysis using the lasso iCluster outperforms the separate clustering approach in subtype
analysis given DNA copy number and mRNA expression data.
- Correlation between data sets is not utilized to inform the clustering analysis, ignoring
an important piece of information that plays a key role for identifying “driver” features
of biological importance.
- Separate analysis of paired genomic data sets is an ineﬃcient use of the available information.
- It is not straightforward to integrate the multiple sets of cluster assignments that are
data-type dependent without extensive prior information on cancer biology.
- The standard clustering method includes all genomic features regardless of their relevance to clustering.
Our method aims to overcome these obstacles by formulating a joint analysis across
6
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multiple omics data sets. The heatmap in Figure 1B demonstrates the superiority of our
working model in correctly identifying the subgroups (vertically divided by solid black lines).
From left to right, cluster 1 (samples labeled in red) corresponds to the breast cancer cell
line subgroup, distinguishing cell line samples from tumor samples. Cluster 2 corresponds
to the HER2 tumor subtype (samples labeled in green), showing concordant ampliﬁcation
in the DNA and overexpression in mRNA at the HER2 locus (chr 17q12). This subtype is
associated with poor survival as shown in Figure 1C. Cluster 3 (samples labeled in black) did
not show any distinct patterns, though a pattern may have emerged if there were additional
data types such as DNA methylation.
The motivation for sparseness in the estimated wk is illustrated by Figure 1D. It clearly
reveals the HER2-subtype speciﬁc genes (including HER2, GRB7, TOP2A). By contrast,
the standard cluster centroid estimation is ﬂooded with noise (Figure 1C), revealing an inherent problem with clustering methods without regularization.
The copy number data example in Figure 1 depicts a narrow (focal) DNA ampliﬁcation
event on a single chromosome involving only a few genes (including HER2). Nevertheless,
copy number is more frequently altered across long contiguous regions. In the lung cancer data example we will discuss in Section 6.2, chromosome arm-level copy number gains
(log-ratio> 0) and losses (log-ratio< 0) as illustrated in Figure 6 are frequently observed,
motivating the use of a fused lasso penalty to account for such structural dependencies. In
the next Section, we discuss methodological details on lasso, fused lasso and elastic net in
the latent variable regression.

3

Method

Assuming Gaussian error terms, equation (1) implies the following conditional distribution
X t |Z ∼ N (W t Z, Ψt ), t = 1, · · · , T.

(2)

Further assuming Z ∼ N (0, I) , the marginal distribution for the observed data is then
X t ∼ N (0, Σt ),

(3)

where Σt = W t W ′t +Ψt . Direct maximization of the marginal data log-likelihood is diﬃcult.
We consider an expectation-maximization (EM) algorithm (Dempster et al., 1977). In the
EM framework, the latent variables are considered “missing data”. Therefore the “complete”
data log-likelihood that consists of these latent variables is
n∑
1
1∑
log |Ψt | −
tr((X t − W t Z)′ Ψt −1 (X t − W t Z)) − tr(Z ′ Z).
2
2
2
T

ℓc ∝ −

t=1

T

(4)

t=1

In the next section, we discuss a penalized complete data log-likelihood to induce sparsity
in W t .
7
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3.1

Penalized Likelihood Approach

As mentioned earlier, sparsity in W t directly impacts the interpretability of the latent variables. A zero entry in the ith row and kth column (wik = 0) means that the ith genomic
feature has no weight on the kth latent variable. If the entire row wi = 0, then this genomic feature has no contribution to the latent variables and is considered noninformative.
We use a penalized complete-data log-likelihood as follows to enforce desired sparsity in the
estimated W t :
T
∑
ℓc,p ({W t }Tt=1 , {Ψ}Tt=1 ) = ℓc −
Jλt (W t ),
(5)
t=1

where ℓc is the complete-data log-likelihood function deﬁned in (4) which controls the ﬁtness
of the model; Jλt (W t ) is a penalty function which controls the complexity of the model; and
λt is a non-negative tuning parameter that determines the balance between the two.
We ﬁrst consider the lasso penalty that takes the form
Jλt (W t ) = λt

pt
K−1
∑∑

|wik |,

(6)

k=1 i=1

where wik is the element in the ith row and kth column of W t . The ℓ1 -penalty continuously
shrinks the coeﬃcients toward zero and thereby yields a substantial decrease in the variance
of the coeﬃcient estimates. Owing to the singularity of ℓ1 -penalty at the origin (wik = 0),
some estimated ŵik will be exactly zero. The degree of sparseness is controlled by the tuning
parameter λt .
To account for the strong spatial dependence along genomic ordering typical in DNA
copy number data, we consider the fused lasso penalty (Tibshirani et al., 2005), which takes
the following form
Jλt (W t ) = λ1t

pt
K−1
∑∑

|wik | + λ2t

k=1 i=1

pt
K−1
∑∑

|wik − w(i−1)k |,

(7)

k=1 i=2

where λ1t and λ2t are two non-negative tuning parameters. The ﬁrst penalty encourages
sparseness while the second encourages smoothness along index i. The Fused Lasso penalty
is particularly suitable for DNA copy number data where contiguous regions of a chromosome tend to be altered in the same fashion (Tibshirani & Wang, 2008).
We also implemented the elastic net penalty (Zou and Hastie, 2005), which takes the
form
pt
pt
K−1
K−1
∑∑
∑∑
2
Jλt (W t ) = λ1t
|wik | + λ2t
wik
,
(8)
k=1 i=1

k=1 i=1
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where λ1t and λ2t are two non-negative tuning parameters. Zou and Hastie (2005) showed
that the elastic net penalty tends to select or remove highly correlated predictors together
in linear regression setting by enforcing their estimated coeﬃcients to be similar. In our
experience, the elastic net penalty tends to be more numerically stable than lasso penalty in
our model.
Figure 2 shows the eﬀectiveness of sparse iCluster using a simulated pair of data sets
(T = 2). We simulated a single length-n latent variable z ∼ N (0, I) where n = 100. The
coeﬃcient matrix W 1 consists of a single column w of length p1 = 200 with the ﬁrst 20
elements set to 1.5 and the remaining elements set to 0, i.e., wi = 1.5 for i = 1, · · · , 20 and
0 elsewhere. The coeﬃcient matrix W 2 consists of a single column of length p2 = 200 and
set to have wi = 1.5 for i = 101, · · · , 120 and 0 elsewhere. The lasso, elastic net (Enet), and
fused lasso coeﬃcient estimates are plotted to contrast the noisy cluster centroids estimated
separately in data type 1 (left) and in data type 2 (right) in the top panel of Figure 2. The
algorithm for computing these sparse estimates will be discussed in Section 4.
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Figure 2: A simulated pair of data sets each with 100 subjects (n = 100) and 200 features
(pt = 200, t = 1, 2), and 2 subgroups (K = 2). Top panel plots the cluster centroids in data
set 1 (left) and in data set 2 (right). Estimated sparse iCluster coeﬃcients are plotted below.
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3.2

Relationship to Singular Value Decomposition (SVD)

An SVD/PCA on the concatenated data matrix X = (X ′1 , · · · , X ′T )′ is a special case of
equation (1) that requires a common covariance matrix across data types. Speciﬁcally, it
can be shown that when Ψ1 = · · · = ΨT = σ 2 I, equation (1) reduces to a “probabilistic
SVD/PCA” on the concatenated data matrix X. Following similar derivation in Tipping
and Bishop (1999), the maximum likelihood estimates of W , where W = (W ′1 , · · · , W ′T )′ is
the concatenated coeﬃcient matrix, coincide with the ﬁrst K − 1 eigenvectors of the sample
covariance matrix XX ′ or the right singular vector of the concatenated data matrix X.
The MLE of σ 2 is the average of the remaining n − K + 1 eigenvalues, capturing the residual
variation averaged over the “lost” dimensions.
The major assumption is the requirement that all features have the same variance. The
genomic data types, however, are fundamentally diﬀerent and the method we propose primarily aims to deal with heteroscedasticity among genomic features of various types. The
common covariance assumption that leads to SVD is therefore not suitable for integrating
omics data types. It is worth mentioning that feature scaling may not necessarily yield
σ12 = · · · = σp2t . In our modeling framework, σi2 is the conditional variance of xij given
z j . Standardization on xij will yield the same marginal variance across features, but the
conditional variances of features are not necessary the same after standardization.
Our method aims to identify common inﬂuences across data types through the latent
component Z. The independent error terms E t , t = 1, · · · , T capture the remaining variances unique to each data type after accounting for the common variance. In SVD, however,
the unique variances are absorbed in the term W Z by enforcing Ψ1 = · · · = ΨT = σ 2 I.
As a result, common and unique variations are no longer separable. This is in fact one of
the fundamental diﬀerences between factor analysis model and PCA, which has practical
importance in integrative modeling.
In Sections 6 and 7, we illustrate that SVD on concatenated data matrix broadly fails
to achieve an eﬀective integration in both simulated and real data sets. By contrast, our
method can more eﬀectively deal with heteroscedasticity among genomic features of various
types. The contrast with a sparse SVD method lies in that our framework allows each block
of the concatenated coeﬃcient matrix to have a diﬀerent sparsity constraint.

3.3

Uniform Sampling

An exhaustive grid search for the optimal combination of the penalty parameters that maximizes a certain criteria (the optimization criteria will be discussed in Section 5) is ineﬃcient
and computationally prohibitive. We use the uniform design (UD) of Fang & Wang (1994)
to generate good lattice points from the search domain, a similar strategy adopted by Wang
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et al. (2008). A key theoretic advantage of UD over the traditional grid search is the uniform space ﬁlling property that avoids wasteful computation at close-by points. Let D be
the search region. Using the concept of discrepancy that measures uniformity on D ⊂ Rd
with arbitrary dimension d, which is basically the Kolmogorov statistic for a uniform distribution on D, Fang and Wang (1994) point out that the discrepancy of the good lattice
point set from a uniform design converges to zero with a rate of O(n−1 (log n)d ), here n (a
prime number) denotes the number of generated points on D. They also point out that the
sequence of equi-lattice points on D has a rate of O(n−1/d ) and the sequence of uniformly
distributed random numbers on D has a rate of O(n−1/2 (log log n)1/2 ). Thus the uniform
design has an optimal rate for d ≥ 2.

4

Algorithm

We now discuss the details of our algorithm for parameter estimation in sparse iCluster. The
latent variables (columns of Z) are considered to be “missing” data. The algorithm therefore
iterates between an E-step for imputing Z and a penalized maximization step (M-step) that
updates the estimates of W t and Ψt for all t. Given the latent variables, the data types are
conditionally independent and thus the integrative omics problem can be decomposed into
solving T independent subproblems with suitable penalty terms. The penalized estimation
procedures are therefore “decoupled” for data type given Z. When convergence is reached,
cluster membership will be assigned for each tumor based on the posterior mean of the latent
variable Z.

E-step In the E-step, we take the expectation of the penalized complete-data log-likelihood ℓc,p
as deﬁned in equations (4) and (5), which primarily involves computing two conditional
expectations given the current parameter estimates:
E[Z|X] = W ′ Σ−1 X
′

′

−1

E[ZZ |X] = I − W Σ

′

W + E[Z|X]E[Z|X] ,

(9)
(10)

where Σ = W W ′ + Ψ and Ψ = diag(Ψ1 , · · · , ΨT ). Here, the posterior mean in (9)
eﬀectively provides a simultaneous rank-(K − 1) approximation to the original data
matrices X.
M-step In the M-step, given the quantities in equations (9) and (10), we maximize the penalized
complete-data log-likelihood to update the estimates of W t and Ψt .
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1. Sparse estimates of W t
For t = 1, · · · , T , we obtain the penalized estimates by
]
1∑ [
Ŵ
,
Ψ̂
E tr((X t − W t Z)′ Ψ−1
(X
−
W
Z))
t
t + Jλt (W t ),
t
t
t
2
T

W t ← argmin
Wt

(11)

t=1

where Ŵ t and Ψ̂t denote the parameter estimates in the last EM iteration. We apply
a local quadratic approximation (Fan & Li, 2001) to the ℓ1 term involved in the penalty
function Jλt (W t ). Using the fact |α| = α2 /|α| when α ̸= 0, we consider the following
quadratic approximation to the ℓ1 term:
λt

pt
K−1
∑∑
k=1 i=1

2
wik
.
|ŵik |

(12)

Due to the uncorrelated error terms (diagonal Ψt ) and “non-coupling” structure of
the lasso and elastic net penalty terms, the estimation of W t can then be computed
feature-by-feature by taking derivatives with respect to each row wi for i = 1, · · · , pt .
The solution for (11) under various penalty terms can then be obtained by iteratively
computing the following ridge regression estimates:
1a. Lasso estimates
For i = 1, · · · , pt ,
( [
)−1
]
[
]
wi = E ZZ ′ X t , Ŵ t , Ψ̂t + Ai
xi E Z X t , Ŵ t , Ψ̂t ,

(13)

where Ai = 2σi2 λt diag{1/|ŵi1 |, . . . , 1/|ŵi(K−1) |}. Unlike the ridge regression applied to
the original features which typically requires the inversion of p × p matrix, computing
(13) only requires the inversion of a (K − 1) × (K − 1) matrix in the latent subspace.
1b. Elastic net estimates
Similarly we consider a quadratic approximation to the ℓ1 term in the elastic net
penalty and obtain the solution for (11) by
( iteratively computing a ridge regression
)
2
estimate similar to (13) but with Ai = 2σi λ1t diag{1/|ŵi1 |, . . . , 1/|ŵi(K−1) |} + λ2t I .
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1c. Fused lasso estimates
For fused lasso penalty terms, we consider the following approximation:
λ1t

p
K−1
∑∑
k=1 i=1

2
∑ ∑ (wik − w(i−1)k )2
wik
+ λ2t
.
|ŵik |
|
ŵ
−
ŵ
|
ik
(i−1)k
k=1 i=2
K−1

p

(14)

In the Fused Lasso scenario, the parameters are coupled together, and the estimation
of wi are no longer separable. However, we circumvent the problem by expressing the
estimating equation in terms of a vectorized form w̃t = vec(W ′t ) = (w1 , · · · , wK−1 )′ ,
a column vector of dimension s = pt · (K − 1) by concatenating the columns of W t .
Then (14) can be expressed in the following form
λ1t w̃′t Aw̃t + λ2t w̃′t Lw̃t ,
where

{
}
A = diag 1/|ŵ1 |, . . . , 1/|ŵs | ,

L = D − M,
{
1/|ŵi − ŵj |, |i − j| = K − 1
(s × s dimension),
M =
0,
otherwise.
D = diag{d1 , . . . , ds } where dj is the summation of the j th row of M .
[
]
[
]
Let C = X t E Z ′ X t , Ŵ t , Ψ̂t , and Q = E ZZ ′ X t , Ŵ t , Ψ̂t , the corresponding
estimating equation is then
∂
(15)
J(w̃) + Q̃w̃ = C̃,
∂ w̃
where
 −2

 −2

σ1 Q
σ1 c′1




..
..
Q̃ = 
(16)
 , C̃ = 
,
.
.
−2
−2 ′
σpt Q
σpt cpt
where cj is the jth row of C. The solution for (11) under the Fused Lasso penalty is
then computed by iteratively computing
(
)−1
C̃.
(17)
w̃t = Q̃ + 2λ1t A + 2λ2t L
2. Estimates of Ψt
Finally for t = 1, · · · , T , we update Ψt in the M-step as follows
Ψt =

]
[
1
diag(X t X ′t − Ŵ t E Z|{X t }Tt=1 , {Ŵ t }Tt=1 , {Ψ̂t }Tt=1 X ′t ).
n

(18)
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The algorithm iterates between the E-step and the M-step as described above until convergence. Cluster membership will then be assigned by applying a standard K-means clustering on the posterior mean E[Z|X]. In other words, cluster partition in the ﬁnal step is
performed in the integrated latent variable subspace of dimension n × (K − 1). Applying kmeans on latent variables to obtain discrete cluster assignment is commonly used in spectral
clustering method (Ng et al., 2002; Rohe et al., 2010).

5

Choice of Tuning Parameters

We use a resampling-based criterion for selecting the penalty parameters and the number
of clusters. The procedure entails repeatedly partitioning the data set into a learning and
a test set. In each iteration, sparse iCluster (for a given K and tuning parameter values)
will be applied to the learning set to obtain a classiﬁer and subsequently predict the cluster
membership for the test set samples. In particular, we ﬁrst obtain parameter estimates from
the learning set. For new observations in the test data X ∗ , we then compute the posterior
′ −1
−1
mean of the latent variables E[Z|X ∗ ] = Ŵ ℓ Σ̂ℓ X ∗ where Ŵ ℓ , Σ̂ℓ denote parameter estimates from the learning set. A K-means clustering is then applied to E[Z|X ∗ ] to partition
the test set samples into K clusters. Denote this as partition C1 . In parallel, the procedure
applies an independent sparse iCluster with the same penalty parameter values to the test
set to obtain a second partition C2 , giving the “observed” test sample cluster labels. Under
the true model, the predicted C1 and the “observed” C2 (regarded as the “truth”) would
have good agreement by measures such as the adjusted Rand index. We therefore deﬁne a
reproducibility index (RI) as the median adjusted Rand index across all repetitions. Values
of RI close to 1 indicate perfect cluster reproducibility and values of RI close to 0 indicate
poor cluster reproducibility. In this framework, the concept of bias, variance, and prediction
error that typically applies to classiﬁcation analysis where the true cluster labels are known
now becomes relevant for clustering. The idea is similar to the “Clest” method proposed
by Dudoit & Fridlyand (2002), the prediction strength measure proposed by Tibshirani &
Walther (2005), and the in-group proportion (IGP) proposed by Kapp & Tibshirani (2007).

6

Results

In this section, we present details of two real data applications.

6.1

Integration of Epigenomic and Transcriptomic Profiling Data
in the Holm Breast Cancer Study

Holm et al. (2010) proﬁled methylation changes in 189 breast cancer samples using Illumina
methylation array for 1,452 CpG sites (corresponding to 803 cancer-related genes) and performed hierarchical clustering on the methylation data alone. Through manual integration,
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the authors then correlated the methylation status with gene expression level for 511 oligonucleotide probes for genes with CpG sites on the methylation assays in the same sample set.
Here we compare clustering of individual data types to various integration approaches.

A

D

B

C

E

Figure 3: Separation of the data points by A. latent variables from sparse iCluster, B. right
singular vectors from SVD of the methylation data alone, C. right singular vectors from SVD
of the expression data alone, D. SVD on the concatenated data matrix, and E. sparse SVD
on the concatenated data matrix. Red dots indicate samples belonging to cluster 1, blue
open triangles indicate samples belonging to cluster 2, and orange pluses indicate samples
belonging to cluster 3.
We applied sparse iCluster for a joint analysis of the methylation and gene expression data
using diﬀerent penalty combinations. In Figure 3A, the ﬁrst two latent variables separated
the samples into three distinct clusters. By associating the cluster membership with clinical
variables, it becomes clear that tumors in cluster 1 are predominantly estrogene receptor
(ER)-negative and associated with the Basal-like breast cancer subtype (Figure 4). Among
the rest of the samples, sparse iCluster further identiﬁes a subclass (cluster 3) that highly
express platelet-derived growth factor receptors (PDGFRA/B), which have been associated
with breast cancer progression (Carvalho et al., 2005).
15
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Cluster 1

Cluster 2

Cluster 3

Basal-like
ER status
BRCA1
BRCA2
PDGFRA
PDGFRB
WNT5A

Figure 4: Integrative clustering of the Holm study DNA methylation and gene expression
data revealed three clusters with a cross-validated reproducibility of 0.7, and distinct clinical
and molecular characteristics.

In Section 3.2, we discussed an SVD approach on combined data matrix as a special
case of our model. Here we present results from SVD and a sparse SVD algorithm proposed
by Witten et al. (2009) on the concatenated data matrix. Figure 3B and 3C indicate that
SVD applied to each data type alone can only separate one out of the three clusters. Figure
3D and 3E indicate that data concatenation does not perform any better in this analysis
than separate analyses of each data type alone. In Sections 7, we will further discuss other
clustering approaches including K-means and a sparse Gaussian mixture model and provide
additional evidence that data concatenation is an inadequate approach for clustering multiple heterogeneous data matrices.
In Table 1, the results from sparse iCluster with two diﬀerent sets of penalty combinations are presented: the combination of (lasso, lasso), and the combination of (lasso, elastic
net) for methylation and gene expression data respectively (Table 1 top panel). The reproducibility index (RI) is computed for various Ks and penalty parameters are sampled
based on a uniform design described in Section 3.3. As described in Section 5, RI (ranges
between 0 and 1) measures the agreement between the predicted cluster membership and
the “observed” cluster membership using a 10-fold cross-validation.
Both methods identiﬁed a 2-cluster solution with an RI around 0.70, distinguishing the
ER-negative, Basal-like subtype from the rest of the tumor samples (Figure 3 and 4, samples
labeled in red). The iCluster(lasso, elastic net) method adds an ℓ2 penalty term to encourage
grouped selection of highly correlated genes in the expression data. This approach further
identiﬁed a 3-cluster solution with high reproducibility (RI=0.70). The additional division
ﬁnds a subgroup that highly express platelet-derived growth factor receptors (Figure 4).
Figure 5 displays heatmaps of the methylation and expression data. Columns are samples
ordered by the integrated cluster assignment. Rows are cluster-discriminating genes (with
nonzero coeﬃcient estimates) grouped into gene clusters by hierarchical clustering. In total,
there are 273 diﬀerentially methylated genes and 182 diﬀerentially expressed genes. Several
cancer genes include MUC1, SERPINA5, RARA, MECP2, RAD50, are hypermethylated
16
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and show concordant underexpression in cluster 1. On the other hand, hypomethylation of
several cancer genes including ETS1, HDAC1, FANCE, RAB32, JAK3 are hypomethylated
and correspondingly show increased expression.
To compare with other methods, we implemented the sparse SVD method by Witten
et al. (2009) and an adaptive hierarchical penalized Gaussian mixture model (AHP-GMM)
by Wang & Zhu (2008) on the concatenated data matrix. None of these methods generated
additional insights beyond separating the ER-negative and Basal-like tumors from the others
(Figure 3 and Table 1). Feature selection is predominantly “biased” toward gene expression features when directly applying sparse SVD on the combined data matrix (bottom panel
of Table 1), likely due to the substantially larger variability observed in gene expression data.

Table 1: Cluster reproducibility and number of genomic feature selected using sparse iCluster, sparse SVD on concatenated data matrix, and Adaptive Hierarchically Penalized Gaussian Mixture Model (AHP-GMM) on concatenated data matrix. K: the number of clusters.
RI: reproducibility index.
iCluster(lasso, lasso)
iCluster(lasso, elastic net)
K RI
Selected
Selected
RI
Selected
Selected
methylation
features

expression
features

methylation
features

expression
features

2
3
4
5

0.68
0.46
0.42
0.42

138
151
150
204
183
398
205
454
sparse SVD

0.70
0.70
0.48
0.47

183
353
273
182
273
182
282
223
AHP-GMM

K

RI

Selected
methylation
features

Selected
expression
features

RI

Selected
methylation
features

Selected
expression
features

2
3
4
5

0.78
0.34
0.27
0.22

1
1
288
273

105
134
511
504

0.93
0.42
0.49
0.43

9
28
116
42

63
105
368
243

17

Hosted by The Berkeley Electronic Press

Cluster 1

Cluster 2

Cluster 1

Cluster 3

Cluster 2

Cluster 3

ETS1
HDAC1
FANCE
KLK10
NGFB
NPY
PLS3
PRKCDBP
RAB32
MMP14
JAK3

MUC1
PDGFB
DDR1
DLC1
RAD50
RARA
SERPINA5
MECP2

MUC1
PDGFB
DDR1
DLC1
RAD50
RARA
SERPINA5
MECP2

ETS1
HDAC1
FANCE
KLK10
NGFB
NPY
PLS3
PRKCDBP
RAB32
MMP14
JAK3

Gene expression heatmap

Methylation heatmap

Figure 5: Integrative clustering of the Holm study DNA methylation and gene expression
data revealed three clusters with a cross-validated reproducibility of 0.7. Selected genes
with negatively correlated methylation and expression changes are indicated to the left of
the heatmap.

6.2

Constructing a Genome-wide Portrait of Concordant Copynumber and Gene Expression Pattern in a Lung Cancer Data
Set

We applied the proposed method to integrate DNA copy number (aCGH data) and mRNA
expression data in a set of 193 lung adenocarcinoma samples (Chitale et al., 2009). Figure
6 displays an example of the probe-level data (log-ratios of tumor versus copy number) on
chromosome 3 and 8 in one tumor sample. Many samples in this data set display similar chr
3p whole-arm loss and chr 3q whole-arm gain.
Arm-length copy number aberrations are surprisingly common in cancer (Beroukhim
et al., 2010), aﬀecting up to thousands of genes within the region of alteration. A broader
challenge is thus to pinpoint the “driver” genes that have functional roles in tumor development from those that are functionally neutral (“passengers”). To that end, an integrative
analysis with gene expression data could provide additional insights. Genes that show concordant copy number and transcriptional activities are more likely to have functional roles.
In search for copy number-associated gene expression patterns, we ﬁt a sparse iCluster
model for each of the 22 chromosomes using (fused lasso, lasso) penalty combination for
joint analysis of copy number and gene expression data. To facilitate comparison, we compute a 2-cluster solution with a single latent variable vector z (instead of estimating K) to
extract the major pattern for each chromosome. Penalty parameter tuning is performed as
described before. In Figure 7, we plot the 22 pairs of the sparse coeﬃcient vectors ordered
by chromosomal position. The coeﬃcients can be interpreted as the diﬀerence between the
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Figure 6: Illustration of copy number probe-level data from a lung tumor sample (Chitale
et al., 2009). Log-ratios of copy number (tumor versus normal) on chromosome 3 and 8 are
displayed. A log-ratio great than zero indicate copy number gain and a log-ratio below zero
indicate loss. Black line indicates the segmented value using the circular binary segmentation
method (Olshen et al., 2004; Venkatraman & Olshen, 2007).
two cluster means. Positive and negative coeﬃcient values in Figure 7A thus indicate copy
number gains and losses in one cluster relative to the other. Similarly, in Figure 7B, coeﬃcient signs indicate over- or under-expression in one cluster relative to the other. Concordant
copy number and gene expression changes can thus be directly visualized from Figure 7.
Several chromosomes (1,3, 8, 10, 15 and 16) show contiguous regions of gains or losses
spanning whole chromosome arms. As discussed before arm-length aberrations can aﬀect
up to thousands of genes within the region of alteration. A great challenge is thus to
pinpoint the “driver” genes that have functional roles in tumor development from those
that are functionally neutral (“passengers”). To that end, an integrative analysis could
provide additional insights. Genes that show concordant copy number and transcriptional
activities are more likely to have functional roles. Figure 7 shows that the application of the
proposed method can unveil a genome-wide pattern of such concordant changes, providing a
rapid way for identifying candidates genes of biological signiﬁcance. Several arm-level copy
number alterations (chromosomes 3, 8, 10, 16) exhibit concerted inﬂuence on the expression
of a small subset of the genes within the broad regions of gains and losses.

7

Simulation

In this section, we present results from two simulation studies. In the ﬁrst simulation
setup, we simulate a single length-n latent variable z ∼ N (0, 1) where n = 100. Subject
j, j = 1, · · · , n belongs to cluster 1 if zj > 0 and cluster 2 otherwise. For simplicity, the pair
of coeﬃcient matrices (W 1 , W 2 ) are of the same dimension 200 × 1 (p1 = p2 = 200), with
wi = 3 for i = 1, · · · , 20 for both data type and zero elsewhere. Next we obtain the data
matrices (X 1 , X 2 ) with each element generated according to equation (1) with standard
normal error terms. This simulation represents a scenario where an eﬀective joint analysis of
two data sets should be expected to enhance the signal strength and thus improve clustering
19
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A

Fused Lasso estimates (DNA copy number data)

B

Lasso estimates (mRNA expression data)

Figure 7: Penalized coeﬃcient vector estimates arranged by chromosome 1 to 22 derived by
iCluster(fused lasso, lasso) applied to the Chitale et al. lung cancer data set. A single latent
variable vector is used to identify the major pattern of each chromosome.
performance.
Table 2 summarizes the performances of each method in terms of the ability to choose
the correct number of clusters, cross-validated error rates, cluster reproducibility. In Table
2, separate K-means methods perform poorly in terms of the ability to choose the correct
number of clusters, cluster reproducibility, and the cross-validation error rates (with respect
to the true simulated cluster membership). K-means on concatenated data performs even
worse, likely due to noise accumulation. For sparse SVD, a cluster assignment step is needed.
We took a similar approach of applying K-means on the ﬁrst K − 1 right singular vectors
of the data matrix. Sparse SVD performs better than simple K-means, though data concatenation does not seem to oﬀer much advantage. In this simulation scenario, AHP-GMM
models show good performance in feature selection (Table 3), but appear to under-estimate
the probability of K = 2. A common theme in this simulation is that a data concatenation
approach is generally ineﬀective regardless of the clustering methods used. By contrast,
sparse iCluster methods achieved an eﬀective integrative outcome across all performance
criteria.
Table 3 summarizes the associated feature selection performance. No numbers are shown
for the standard K-means methods as they do not have an inherent feature selection method.
Among the methods, sparse iCluster methods perform the best in identifying the true posi20
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tive features while keeping the number of false positives close to 0.
In the second simulation, we vary the setup as follows. We simulate 150 subjects belonging to three clusters (K = 3). Subject j = 1, · · · , 50 belong to cluster 1, subject j = 51 − 100
belong to cluster 2, and subject j = 101, · · · , 150 belong to cluster 3. A total of T = 2 data
types (X 1 , X 2 ) are simulated each has p1 = p2 = 500 features. Here each data type alone
only deﬁne two clusters out of the three. In data set 1, xij ∼ N (2, 1) for i = 1, · · · , 10 and
j = 1, · · · , 50, xij ∼ N (1.5, 1) for i = 491, · · · , 500 and j = 51 − 100, and xij ∼ N (0, 1)
for the rest. In data set 2, xij = 0.5 ∗ xij + e where e ∼ N (0, 1) for j = 1, · · · , 50 and
i = 1, · · · , 10, xij ∼ N (2, 1) for j = 101, · · · , 150 and i = 491, · · · , 500, and xij ∼ N (0, 1)
for the rest. The ﬁrst 10 features are correlated between the two data types. In Table 4
and 5, the sparse iCluster methods consistently performs the best in clustering and feature
selection.

7.1

Implementation and running time

The core iCluster EM iterations are implemented in C. Table 3 shows some typical computation times for problems of various dimensions on a 3.2 GHz Xeon Linux computer.

8

Discussion

Integrative genomics is a new area of research accelerated by large-scale cancer genome efforts including the Cancer Genome Atlas Project. New integrative analysis methods are
emerging in this ﬁeld. Van Wieringen & Van de Wiel (2009) proposed a nonparametric
testing procedure for DNA copy number induced diﬀerential mRNA gene expression. Peng
et al. (2010) and Vaske et al. (2010) considered pathway and network analysis using multiple
genomic data sources. A number of others (Waaijenborg et al., 2008; Parkhomenko et al.,
2009; Le Cao et al., 2009; Witten et al., 2009; Witten & Tibshirani, 2009; Soneson et al.,
2010) suggested using canonical correlation analysis (CCA) to quantify the correlation between two data sets (e.g., gene expression and copy number data). Most of these previous
work focused on integrating copy number and gene expression data, and none of these methods were speciﬁcally designed for tumor subtype analysis.
We have formulated a penalized latent variable model for integrating multiple genomic
data sources. The latent variables can be interpreted as a set of distinct underlying cancer
driving factors that explain the molecular phenotype manifested in the vast landscape of
alterations in the cancer genome, epigenome, transcriptome. Lasso, elastic net, and fused
lasso penalty terms are used to induce sparsity in the feature space. We derived an eﬃcient
and uniﬁed algorithm. The implementation scales well for increasing data dimension.
A future extension on group-structured penalty terms is to incorporate a grouping struc-
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Table 2: Clustering performance summarized over 50 simulated data sets under setup 1
(K=2). Separate clustering methods have two sets of numbers associated with model ﬁt
to each individual data type. Number in parentheses is the standard deviation over 50
simulations.
Cluster
Method
Frequency Crossof choosing validation
Reprothe correct error rate
ducibility
K
Separate K-means
58
0.08 (0.04)
0.67 (0.17)
62
0.08 (0.04)
0.70 (0.19)
Concatenated Kmeans
50
0.06 (0.04)
0.66 (0.19)
Separate sparse SVD
74
0.07 (0.06)
0.71 (0.13)
76
0.07 (0.07)
0.72 (0.12)
Concatenated Sparse SVD
78
0.07 (0.08)
0.70 (0.12)
Separate AHP-GMM
38
0.06 (0.04)
0.72 (0.15)
40
0.05 (0.04)
0.74 (0.14)
Concatenated AHP-GMM
46
0.06 (0.04)
0.75 (0.13)
Lasso iCluster
90
0.04 (0.02)
0.81 (0.08)
Enet iCluster
94
0.03 (0.02)
0.85 (0.07)
Fused Lasso iCluster
94
0.03 (0.02)
0.83 (0.08)
Table 3: Feature selection performance summarized over 50 simulated data sets for K = 2.
There are a total of 20 true features simulated to distinguish the two sample clusters.
Data 1
Data 2
True
False
True
False
Method
positives positives positives positives
Separate Kmeans
–
–
–
–
Concatenated Kmeans
–
–
–
–
Separate Sparse SVD
18.7 (3.2) 21.5 (37.7) 18.8 (2.9) 27.4 (43.6)
Concatenated Sparse SVD 14.0 (5.3) 22.5 (16.1) 13.7 (5.2) 22.8 (16.4)
Separate AHP-GMM
19.6 (2.1) 0.02 (0.16) 19.1 (3.1)
0 (0)
Concatenated AHP-GMM 18.8 (3.6) 0.02 (0.15) 18.6 (4.0) 0.02 (0.15)
Lasso iCluster
20 (0)
0.07 (0.3)
20 (0)
0.07 (0.3)
Enet iCluster
20 (0)
0.1 (0.3)
20 (0)
0.02 (0.1)
Fused Lasso iCluster
20 (0)
0 (0)
20 (0)
0 (0)
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Table 4: Clustering performance summarized over 50 simulated data sets under setup 2
(K=3).
Method
Cluster
Frequency Crossof choosing validation
Reprothe correct error rate
ducibility
K
Separate K-means
2
0.33 (0.001)
0.54 (0.07)
0
0.33 (0.002)
0.47 (0.04)
Concatenated Kmeans
100
0.01 (0.07)
0.96 (0.03)
Separate sparse SVD
0
0.28 (0.10)
0.45 (0.03)
0
0.31 (0.07)
0.44 (0.04)
Concatenated Sparse SVD
16
0.01 (0.002)
0.59 (0.05)
Separate AHP-GMM
0
0.07 (0.13)
0.63 (0.05)
0
0.32 (0.02)
0.54 (0.06)
Concatenated AHP-GMM
100
0.01 (0.07)
0.98 (0.03)
Lasso iCluster
100
0.0003 (0.001) 0.98 (0.01)
Enet iCluster
100
0.0003 (0.001) 0.97 (0.02)
Fused Lasso iCluster
100
0 (0)
0.94 (0.05)
Table 5: Feature selection performance summarized over 50 simulated data sets under K = 3.
Data 1
Data 2
True
False
True
False
Method
positives
positives positives
positives
Separate Kmeans
–
–
–
–
Concatenated Kmeans
–
–
–
–
Separate Sparse SVD
19.8 (0.7) 349.6 (167.1) 19.9 (0.3) 347.5 (142.5)
Concatenated Sparse SVD
20 (0)
396.6 (128.7) 19.6 (1.6) 395.4 (128.3)
Separate AHP-GMM
15.8 (5.0) 239.9 (245.5) 15.5 (5.5) 269.9 (246)
Concatenated AHP-GMM 19.2 (1.7)
0.33 (0.64)
14.4 (4.0)
0.21 (0.66)
Lasso iCluster
20 (0)
1.5 (1.4)
19.9 (0.2)
1.9 (1.5)
Enet iCluster
20 (0)
0.5 (0.6)
19.8 (0.5)
0.7 (1.0)
Fused Lasso iCluster
20 (0)
0 (0)
20 (0)
0 (0)
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Table 6: Computing time (in seconds) for typical runs of sparse iCluster under various
dimension.
Time (in seconds)
p
N
Lasso iCluster Elasticnet iCluster Fused Lasso iCluster
200 100
0.10
0.11
0.37
0.50
0.36
3.56
500 100
1.40
1.45
25.05
1000 100
2000 100
6.49
5.90
76.40
18.93
18.94
33 (min)
5000 100
ture deﬁned a priori. Two types of group structures are relevant for our application. One
is to treat the wi1 , · · · , wi(K−1) as a group since they are associated with the same feature.
Yuan and Lin’s group lasso penalty Yuan & Lin (2006) can be applied directly. Similar to
our current algorithm, by using Fan and Li’s local quadratic approximation, the problem
reduces to a ridge-type regression in each iteration. The other extension is to incorporate
the grouping structure among features to boost the signal to noise ratio, for example, to
treat the genes within a pathway as a group. We can consider a hierarchical lasso penalty
(Wang et al., 2009) to achieve sparsity at both group level and individual variable level.
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